Bluebee raises €1.75 million to bring supercomputing to genomics
Founded in 2011 as a spin-off of the Delft University of Technology and Imperial College London, Bluebee offers a cloud-based, distributed computing solution combined with accelerated hardware. This allows mass sequencing data volumes to be processed in extremely short timeframes.
“Time-to-diagnosis is crucial for patients and can mean the difference between life and death, a notable example being neonatal cancer patients where every day counts." says Hans Cobben, CEO of Bluebee. “But beyond that, moving one step closer to truly targeted medicine will prove to be a game changer for the medical as well as the pharmaceutical industry. Innovative technologies in genetic screening and analytics will enable the introduction of completely new diagnostics and therapies in healthcare.”
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.